Readministration of Nivolumab after Persistent Immune-related Colitis in a Patient with Recurrent Melanoma

Nivolumab shows promising efficacy against metastatic melanoma. However, immune-related adverse events are of great concern. We herein report a case of persistent colitis that developed during nivolumab monotherapy and nivolumab readministration. An 82-year-old Japanese woman with recurrent melanoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Yosuke, Nishikawa, Yoshitaka, Nomura, Motoo, Miyamoto, Shin'ich, Uneno, Yu, Horimatsu, Takahiro, Muto, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938514/
https://www.ncbi.nlm.nih.gov/pubmed/29269640
http://dx.doi.org/10.2169/internalmedicine.8910-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938514/
https://www.ncbi.nlm.nih.gov/pubmed/29269640
http://dx.doi.org/10.2169/internalmedicine.8910-17

Ejemplares similares